CYTOS
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.
CYTOS
Industry:
Biotechnology Hospital Pharmaceutical
Founded:
1995-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.cytos.com
Total Employee:
51+
Status:
Active
Contact:
4117334644
Total Funding:
125.57 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS 1and1
Similar Organizations
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Triskel Biopharmaceuticals AG
Triskel Biopharmaceuticals AG is specialised in the development of late stage and clearly differentiated biotechnology drugs
Founder
Stock Details
Investors List
Amgen Ventures
Amgen Ventures investment in Post-IPO Equity - Cytos
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Cytos
Abingworth
Abingworth investment in Post-IPO Equity - Cytos
venBio Partners
venBio Partners investment in Post-IPO Equity - Cytos
Alta Partners
Alta Partners investment in Series B - Cytos
HealthCap
HealthCap investment in Series B - Cytos
Novartis
Novartis investment in Series B - Cytos
Aventic Partners AG
Aventic Partners AG investment in Series B - Cytos
New Medical Technologies
New Medical Technologies investment in Series B - Cytos
Lombard Odier
Lombard Odier investment in Series B - Cytos
Official Site Inspections
http://www.cytos.com
- Host name: decimus.sui-inter.net
- IP address: 80.74.142.130
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Cytos"
Cytos - Crunchbase Company Profile & Funding
Organization. Cytos . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Cytos is a public …See details»
Cytos - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Cytos Biotechnology AG Overview | SignalHire Company Profile
Cytos Biotechnology AG is a public company that has been in the industry for 24 years. The company currently specializes in the Biotechnology area. ... Organization Website. cytos.com . …See details»
Cytos Biotechnology Ltd. will be renamed Kuros Biosciences Ltd ...
Jan 8, 2016 Cytos Biotechnology Ltd (“Cytos” or the “Company” – to be renamed Kuros Biosciences Ltd.), announced today that the Board of Directors has constituted itself with Dr. …See details»
Cytos Biotechnology 2025 Company Profile: Valuation, …
Abingworth, Adamant Biomedical Investment, Aisling Capital, Alta Partners, and Amgen are 5 of 18 investors who have invested in Cytos Biotechnology. Who …See details»
Cytos - Crunchbase
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies .See details»
Cytos Biotechnology AG - VentureRadar
Find out more about Cytos Biotechnology AG, Drug Development and Biotech, Drug development, Life Sciences, Life Science, Healthtech and and . All; Ranked; Organisation …See details»
Cytos.com - AboutUs
Title. Cytos Description. Creates new technologies and products for broad markets by innovations in the biomedical sciences. Additional InformationSee details»
Cytos Biotechnology AG - DevelopmentAid
Dec 6, 2024 Cytos Biotechnology AG — Consulting Organization from Switzerland with 51-200 employees, has experience with The Seventh Framework Programme, it`s involved in …See details»
Cytos - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cytos with its drug pipeline, therapeutic area, technology platform, .See details»
Cytos Biotechnology Ltd. will be renamed Kuros Biosciences Ltd ...
Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren Switzerland Tel: +41 44 733 47 47 Fax: +41 44 733 47 40 info@cytos.com www.cytos.com MEDIA RELEASE COMMUNIQUE AUX …See details»
Welcome to Cytomos
AuraCyt™ from Cytomos is harnessing the combined power of dielectric spectroscopy and consumer microelectronics to generate multidimensional data for single cells, without the need …See details»
Cytos - Recent News & Activity - Crunchbase
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies . Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Laboratório Cytos - Anatomia Patológica e Análises Clínicas | Os ...
Os Laboratórios Cytos são especializados em diagnósticos médicos nas áreas de anatomia patológica, citologia e análises clínicas. e contam com uma ampla equipe de profissionais …See details»
KYTOS – Microbiome Management as a Service
We believe the best way to avoid catastrophic crop losses is to work with, rather than against your microbiome. But managing microbiomes is hard—there are over 1 quadrillion (10 15) microbial …See details»
Cytos Biotechnology AG | ETH Zurich - ETH Zürich
Cytos developed immunodrugs, a new class of biopharmaceutical preparations for the prevention and treatment of chronic diseases, e.g. asthma. In 2002 the publicly listed company Asklia …See details»
Mytos - Home
The Mytos Platform is infrastructure for fully automated manufacture of any human cell typeSee details»
CytoSen Therapeutics - Crunchbase Company Profile & Funding
CytoSen Therapeutics is an innovative team of medical and scientific professionals on a mission to advance natural (NK) cell therapeutics and to make it a real cure in the fight with cancer.See details»
Cytos Biotechnology AG (Cytos Biotechnology AG) - 药物管线_专 …
May 1, 2023 了解Cytos Biotechnology AG (Cytos Biotechnology AG)公司的药物管线，治疗领域，技术平台，以及它的24项临床试验, 9篇新闻和27篇文献，疾病领域:内分泌与代谢疾病，神 …See details»
Encytos
Encytos offers an innovative cell culture platform. Our technology is based on an inorganic topographic structured surface that does not require the addition of extracellular matrix …See details»